Evidence map›Paper›PMID 31487241›Full record

ArticleeLife2019

Altered gating of K

Bernadette O'Donovan, Adewale Adeluyi, Erin L Anderson, Robert D Cole, Jill R Turner, Pavel I Ortinski

Abstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. The involvement of KTranslational psychiatry · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Open channel block of Kv1.4 potassium channels by aripiprazole.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2020
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bernadette O'DonovanDepartment of Neuroscience, University of Kentucky, Lexington, United States.ORCID 0000-0002-3591-0560
Adewale AdeluyiDepartment of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, United States.
Erin L AndersonDepartment of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, United States.ORCID 0000-0002-4731-001X
Robert D ColeDepartment of Neuroscience, University of Kentucky, Lexington, United States.
Jill R TurnerCollege of Pharmacy, University of Kentucky, Lexington, United States.
Pavel I OrtinskiDepartment of Neuroscience, University of Kentucky, Lexington, United States.ORCID 0000-0003-0814-4490

Funding

Training in Drug Abuse Related Research.T32DA016176 · NIDA · UNIVERSITY OF KENTUCKY · PI DWOSKIN, LINDA P · 2004 to 2020
$4.0M
Dynamic Signaling of NRG3-ErbB4 in the Hippocampus Mediates Nicotine Withdrawal PhenotypesR01DA044311 · NIDA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI TURNER, JILL R. · 2018 to 2022
$1.9M
Neural microcircuit selection by astrocyte signaling following cocaine exposureR01DA041513 · NIDA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI ORTINSKI, PAVEL IVANOVICH · 2017 to 2021
$1.6M
Pharmacogenomic Analysis of Nicotine DependenceR00DA032681 · NIDA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI TURNER, JILL R. · 2014 to 2016
$741k
Control of Cocaine Seeking by D1-dependent Modulation of NMDA SignalingK01DA031747 · NIDA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI ORTINSKI, PAVEL IVANOVICH · 2012 to 2016
$696k
Pharmacogenomic Analysis of Nicotine DependenceK99DA032681 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI TURNER, JILL R. · 2013 to 2013
$133k
NIDA NIH HHS DA016176NIDA NIH HHS DA031747NIDA NIH HHS DA032681NIDA NIH HHS DA041513NIDA NIH HHS DA044311NIDA NIH HHS K01 DA031747NIDA NIH HHS K99 DA032681NIDA NIH HHS R00 DA032681NIDA NIH HHS R01 DA041513NIDA NIH HHS R01 DA044311NIDA NIH HHS T32 DA016176
6 · The paper itself

Abstract

Deficient motivation contributes to numerous psychiatric disorders, including withdrawal from drug use, depression, schizophrenia, and others. Nucleus accumbens (NAc) has been implicated in motivated behavior, but it remains unclear whether motivational drive is linked to discrete neurobiological mechanisms within the NAc. To examine this, we profiled cohorts of Sprague-Dawley rats in a test of motivation to consume sucrose. We found that substantial variability in willingness to exert effort for reward was not associated with operant responding under low-effort conditions or stress levels. Instead, effort-based motivation was mirrored by a divergent NAc shell transcriptome with differential regulation at potassium and dopamine signaling genes. Functionally, motivation was inversely related to excitability of NAc principal neurons. Furthermore, neuronal and behavioral outputs associated with low motivation were linked to faster inactivation of a voltage-gated potassium channel, K

Indexed as

MotivationRewardAnimalsKv1.4 Potassium ChannelNeuronsNucleus AccumbensRats, Sprague-DawleyKv1.4 Potassium Channelkv 1.4motivationneurosciencenucleus accumbenspatch-clamppotassiumrattranscriptome

Identifiers

PMID31487241
PMCPMC6728144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.